Your browser doesn't support javascript.
loading
Serious hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants: an exposed-unexposed cohort study in December 2021 from the COVID-19 surveillance databases in France
Vincent Auvigne; Sophie Vaux; Yann Le Strat; Justine Schaeffer; Lucie Fournier; Cynthia Tamandjou; Charline Montagnat; Bruno Coignard; Daniel Levy-Bruhl; Isabelle Parent du Chatelet.
Afiliação
  • Vincent Auvigne; Sante publique France
  • Sophie Vaux; Sante publique France
  • Yann Le Strat; Sante publique France
  • Justine Schaeffer; Sante publique France
  • Lucie Fournier; Sante publique France
  • Cynthia Tamandjou; Sante publique France
  • Charline Montagnat; Sully
  • Bruno Coignard; Sante publique France
  • Daniel Levy-Bruhl; Sante publique France
  • Isabelle Parent du Chatelet; Sante publique France
Preprint em Inglês | medRxiv | ID: ppmedrxiv-22269952
ABSTRACT
BackgroundA rapid increase in incidence of the SARS-CoV-2 Omicron variant occurred in France in December 2021, while the Delta variant was prevailing since July 2021. We aimed to determine whether the risk of a severe hospital event following symptomatic SARS-CoV-2 infection differs for Omicron versus Delta. MethodsWe conducted a retrospective cohort study to compare severe hospital events (admission to intensive care unit or death) between Omicron and Delta symptomatic cases matched according to week of virological diagnosis and age. The analysis was adjusted for age, sex, vaccination status, presence of comorbidities and region of residence, using Cox proportional hazards model. FindingsBetween 06/12/2021-28/01/2022, 184 364 cases were included, of which 931 had a severe hospital event (822 Delta, 109 Omicron). The risk of severe event was lower among Omicron versus Delta cases; the difference in severity between the two variants decreased with age (aHR=0{middle dot}11 95%CI 0{middle dot}07-0{middle dot}17 among 40-64 years, aHR=0{middle dot}51 95%CI 0{middle dot}26-1{middle dot}01 among 80+ years). The risk of severe event increased with the presence of comorbidities (for very-high-risk comorbidity, aHR=4{middle dot}18 95%CI 2{middle dot}88-6{middle dot}06 among 40-64 years) and in males (aHR=2{middle dot}29 95%CI 1{middle dot}83-2{middle dot}86 among 40-64 years) and was higher in unvaccinated compared to primo-vaccinated (aHR=6{middle dot}90 95%CI 5{middle dot}26-9{middle dot}05 among 40-64 years). A booster dose reduced the risk of severe hospital event in 80+ years infected with Omicron (aHR=0{middle dot}27; 95%CI 0{middle dot}11-0{middle dot}65). InterpretationThis study confirms the lower severity of Omicron compared to Delta. However, the difference in disease severity is less marked in the elderly.
Licença
cc_by
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Cohort_studies / Estudo observacional / Estudo prognóstico Idioma: Inglês Ano de publicação: 2022 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Cohort_studies / Estudo observacional / Estudo prognóstico Idioma: Inglês Ano de publicação: 2022 Tipo de documento: Preprint
...